Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1985 Jul;30(1):66-77.
doi: 10.2165/00003495-198530010-00007.

Primary oesophageal motility disorders. Current therapeutic concepts

Review

Primary oesophageal motility disorders. Current therapeutic concepts

M Traube et al. Drugs. 1985 Jul.

Abstract

Various oesophageal manometric disorders have been associated with chest pain or dysphagia. The classic motility disorders are achalasia and diffuse oesophageal spasm. In achalasia, a disorder of aperistalsis in the oesophageal body and incomplete relaxation of the lower oesophageal sphincter, either surgical myotomy or pneumatic dilatation is an effective approach, although some investigators have suggested a role for pharmacological therapy. For the treatment of diffuse oesophageal spasm, a disorder of non-peristaltic motor activity in the oesophagus, various pharmacological approaches with nitrates, anticholinergics, and calcium antagonists have been used. In the presence of associated lower oesophageal sphincter dysfunction, bouginage or pneumatic dilatation may be indicated. Long oesophagomyotomy should be considered for those patients who fail to respond to these measures. Recent manometric techniques have led to the identification of patients with chest pain or dysphagia who have abnormalities of increased contractile amplitude ('nutcracker' oesophagus) or duration. An association with gastro-oesophageal reflux or with psychiatric disturbance has been suggested. Treatment directed towards these factors is indicated and may be supplemented by pharmacological intervention, e.g. by calcium antagonists or anticholinergics.

PubMed Disclaimer

References

    1. N Engl J Med. 1983 Dec 1;309(22):1382-3 - PubMed
    1. Am J Physiol. 1981 Apr;240(4):G290-6 - PubMed
    1. J Clin Gastroenterol. 1984 Apr;6(2):139-42 - PubMed
    1. Gastroenterology. 1982 Nov;83(5):963-9 - PubMed
    1. Dig Dis Sci. 1983 Jun;28(6):481-5 - PubMed

MeSH terms

LinkOut - more resources